Psoriasis drug interaction study completed: no major breakthrough, but key safety data gathered
NCT ID NCT06610890
First seen Dec 08, 2025 · Last updated Apr 30, 2026 · Updated 17 times
Summary
This completed Phase 1 study involved 20 adults with psoriasis to see how Hemay005 tablets affect the way the body processes another drug (midazolam). Researchers also checked for heart rhythm changes and measured inflammation markers. The goal was to gather safety and interaction information, not to treat the disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PSORIASIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Union Hospital of Tongji Medical College, Huazhong University of Science and Technology
Wuhan, Hubei, China
Conditions
Explore the condition pages connected to this study.